Cited by 848Cancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyImmune cells in cancer

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Open access

Scharping, Nicole E., Menk, Ashley V., Moreci, Rebecca S., Whetstone, Ryan D., Dadey, Rebekah E., Watkins, Simon C., Ferris, Robert L., Delgoffe, Greg M.·2016·Immunity

DOI 10.1016/j.immuni.2016.07.009PMC PMC5207350

Open this paper in CoChat — free account Open PDF

Abstract

Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1α (PGC1α), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1α resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2016.07.009

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294

Show all 44 references

Research works printed but not linked: 1

Scarpulla, 2011, Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta (BBA) -, Molecular Cell Research, 1813, 1269

Sorted by citations

Items 401–500 of 847

Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy
Bahrambeigi, S., Molaparast, M., Sohrabi, F., Seifi, L., Faraji, A., Fani, S., & Shafiei‐Irannejad, V. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.01.006 · Cited by 21
Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
Etxeberría, I., Olivera, I., Bolaños, E., Cirella, A., Teijeira, Á., Berraondo, P., & Melero, I. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0464-1 · Cited by 23
IL-13Rα2 humanized scFv-based CAR-T cells exhibit therapeutic activity against glioblastoma
Xu, C., Bai, Y. Y., An, Z., Hu, Y., Zhang, C., & Zhong, X. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.01.002 · Cited by 21
Metabolic reprogramming of tumor microenviroment by engineered bacteria
Wang, H., Xu, F., & Wang, C. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.003 · Cited by 20
Nutrient allocation fuels T cell-mediated immunity
Longo, J., Watson, M. J., Williams, K. S., Sheldon, R. D., & Jones, R. G. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.09.008 · Cited by 19
Fatty Acid Metabolism and T Cells in Multiple Sclerosis
Pompura, S. L., Hafler, D. A., & Dominguez‐Villar, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869197 · Cited by 23
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality
Krug, A., Tari, G., Saidane, A., Gaulard, P., Ricci, J., Lemonnier, F., & Verhoeyen, E. (2022) · Cancers · doi:10.3390/cancers14102392 · Cited by 22
Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets
Zhong, X., He, Z., Li, Y., Fan, Y., Yu, T., Kang, Y., & Bi, Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20656 · Cited by 20
TIMP1/CHI3L1 facilitates glioma progression and immunosuppression via NF-κB activation
Xu, J., Wei, C., Wang, C., Li, F., Wang, Z., Xiong, J., Zhou, Y., Li, S., Liu, X., Yang, G., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167041 · Cited by 20
Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity
Andrews, A. M., Tennant, M. D., & Thaxton, J. E. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02740-3 · Cited by 19
Rapamycin enhances CAR-T control of HIV replication and reservoir elimination in vivo
Mu, W., Tomer, S., Harding, J. S., Kedia, N., Rezek, V. K., Cook, E., Patankar, V., Carrillo, M. A., Martin, H. A., Ng, H. L., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185489 · Cited by 20
USP30 inhibition augments mitophagy to prevent T cell exhaustion
Zhang, R., Gao, F., Li, J., Jin, J., Chen, K., Chaudhuri, S., Liao, Z., Xiao, T., Yang, X., Wen, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adv6902 · Cited by 21
5‐Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death‐ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model
Hu, X., Que, W., Hirano, H., Wang, Z., Nozawa, N., Ishii, T., Ishizuka, M., Ito, H., Takahashi, K., Nakajima, M., et al. (2021) · Cancer Science · doi:10.1111/cas.14930 · Cited by 19
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
Oberholtzer, N. P., Quinn, K. M., Chakraborty, P., & Mehrotra, S. (2022) · Cells · doi:10.3390/cells11040708 · Cited by 19
PGC-1β maintains mitochondrial metabolism and restrains inflammatory gene expression
Guak, H., Sheldon, R. D., Beddows, I., Ark, A. V., Weiland, M. J., Shen, H., Jones, R. G., St‐Pierre, J., Ma, E. H., & Krawczyk, C. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-20215-6 · Cited by 17
Metabolic and epigenetic orchestration of (CAR) T cell fate and function
Akbari, B., Hosseini, Z., Shahabinejad, P., Ghassemi, S., Mirzaei, H. R., & O’Connor, R. S. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215948 · Cited by 20
Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness
Tian, H., Chai, D., Wang, G., Wang, Q., Sun, N., Jiang, G., Li, H., Song, J., Fang, L., Wang, M., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03407-5 · Cited by 21
Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements
Dougé, A., El-Ghazzi, N., Lemal, R., & Rouzaire, P. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0310 · Cited by 21
Cystathionine‐gamma‐lyase overexpression in T cells enhances antitumor effect independently of cysteine autonomy
Lancien, M., Gueno, L., Salle, S., Mérieau, E., Bériou, G., Nguyen, T. H., Abidi, A., Dilek, N., Solomon, P., Poschmann, J., et al. (2021) · Cancer Science · doi:10.1111/cas.14862 · Cited by 19
Low-Temperature EPR Spectroscopy as a Probe-Free Technique for Monitoring Oxidants Formed in Tumor Cells and Tissues: Implications in Drug Resistance and OXPHOS-Targeted Therapies
Kalyanaraman, B., Cheng, G., Zielonka, J., & Bennett, B. (2018) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-018-0858-1 · Cited by 19
Moderate-intensity aerobic exercise training improves CD8+ tumor-infiltrating lymphocytes effector function by reducing mitochondrial loss
Voltarelli, V. A., Amano, M. T., Tobias, G. C., Borges, G. S., da Paixão, A. O., Pereira, M. G., Câmara, N. O. S., Caldeira, W., Ribeiro, A. F., Le, O., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110121 · Cited by 18
Modulating lipid metabolism improves tumor immunotherapy
Yu, P., Fan, Q., & Zhang, Y. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010824 · Cited by 19
Endoplasmic Reticulum Stress and Its Role in Metabolic Reprogramming of Cancer
Zarrella, S., Miranda, M. R., Covelli, V., Restivo, I., Novi, S., Pepe, G., Tesoriere, L., Rodriquez, M., Bertamino, A., Campiglia, P., et al. (2025) · Metabolites · doi:10.3390/metabo15040221 · Cited by 21
Active aldehydes accelerate CD8+ T cell exhaustion by metabolic alteration in the tumor microenvironment
Haku, Y., Kitaoka, K., Ichimaru, K., Hirano, T., Wang, J., Sonomura, K., Maruo, A., Hirose, S., Wang, Y., Ito, K., et al. (2026) · Nature Immunology · doi:10.1038/s41590-025-02370-w · Cited by 19
Intrinsic and Extrinsic Determinants of T Cell Metabolism in Health and Disease
Munford, H., & Dimeloe, S. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00118 · Cited by 19
The Natural History of T Cell Metabolism
Braun, M. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136779 · Cited by 18
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma
Ganly, I., Liu, E. M., Kuo, F., Makarov, V., Dong, Y., Park, J., Gong, Y., Gorelick, A. N., Knauf, J. A., Benedetti, E., et al. (2022) · Science Advances · doi:10.1126/sciadv.abn9699 · Cited by 18
Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
Xia, H., Huang, Z., Wang, Z., Liu, S., Zhao, X., You, J., Xu, Y., Yam, J. W. P., & Cui, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.953668 · Cited by 18
Methionine uptake via the SLC43A2 transporter is essential for regulatory T-cell survival
Saini, N., Saini, N., Metur, S. P., Gahlot, P., Walvekar, A. S., Dutta, A., Davathamizhan, U., Sarin, A., & Laxman, S. (2022) · Life Science Alliance · doi:10.26508/lsa.202201663 · Cited by 18
Metabolic Challenges in Anticancer CD8 T Cell Functions
Amitrano, A. M., & Kim, M. (2023) · Immune Network · doi:10.4110/in.2023.23.e9 · Cited by 20
T-cell dysfunction in natural killer/T-cell lymphoma
Feng, X., Meng, M., Li, H., Gao, Y., Song, W., Di, R., Li, Z., Zhang, X., & Zhang, M. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2212532 · Cited by 18
State of CD8+ T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: From pathogenesis to immunotherapy
Zhong, X., Lv, M., Ma, M., Huang, Q., Hu, R., Li, J., Yi, J., Sun, J., & Zhou, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115131 · Cited by 20
CD39hi identifies an exhausted tumor-reactive CD8+ T cell population associated with tumor progression in human gastric cancer
Shen, Y., Qiu, Y., Duan, Z., Li, Y.-X., Wang, Y., Zhang, Y., Zhu, B., Yu, X.-H., Tan, X., Chen, W., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107122 · Cited by 19
Immune-inflammatory modulation by natural products derived from edible and medicinal herbs used in Chinese classical prescriptions
Kang, Q., He, L., Zhang, Y., Zhong, Z., & Tan, W. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155684 · Cited by 19
A Review of Advances in Mitochondrial Research in Cancer
Li, Z., Zhang, W., Guo, S., Qi, G., Huang, J., Gao, J., Zhao, J., Kang, L., & Li, Q. (2024) · Cancer Control · doi:10.1177/10732748241299072 · Cited by 22
An exacerbated metabolism and mitochondrial reactive oxygen species contribute to mitochondrial alterations and apoptosis in CD4 T cells during the acute phase of Trypanosoma cruzi infection
Ana, Y., Márquez, J. D. R., Fozzatti, L., Baigorrí, R. E., Marín, C., Maletto, B. A., Cerbán, F. M., Radí, R., Piacenza, L., & Stempin, C. C. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.009 · Cited by 18
Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity
Zhao, J., Hu, S., Qi, Z., Xu, X., Long, X., Huang, A., Liu, J., & Cheng, P. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009768 · Cited by 19
Immunometabolite L-2-HG promotes epigenetic modification of exhausted T cells and improves antitumor immunity
Yang, Y., Li, X., Liu, F., Ma, M., Yang, Y., Ruan, C., Lü, Y., Li, X., Wang, X., Shi, Y., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.174600 · Cited by 19
The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction
Cheng, H., Su, Y., Pan, X., Xu, Y., Xie, E., Du, J., Chen, D. G., Dai, X., Gottardo, R., Greenberg, P. D., et al. (2026) · Nature · doi:10.1038/s41586-025-09926-8 · Cited by 18
Allotransplantation Is Associated With Exacerbation of CD8 T-Cell Senescence: The Particular Place of the Innate CD8 T-Cell Component
Daniel, L., Tassery, M., Lateur, C., Thierry, A., Herbelin, A., Gombert, J., & Barbarin, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674016 · Cited by 17
Impact of tumor microenvironment on adoptive T cell transfer activity
Martín-Otal, C., Navarro, F. C., Casares, N., Lasarte-Cía, A., Sánchez-Moreno, I., Hervás‐Stubbs, S., Lozano, T., & Lasarte, J. J. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.002 · Cited by 18
Focus on T cell exhaustion: new advances in traditional Chinese medicine in infection and cancer
Li, S., Hao, L., Zhang, J., Deng, J., & Hu, X. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00785-x · Cited by 17
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy
Chen, C., Han, P., & Qing, Y. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103579 · Cited by 17
Cutting Edge: Glycolytic Metabolism and Mitochondrial Metabolism Are Uncoupled in Antigen-Activated CD8+ Recent Thymic Emigrants
Cunningham, C. A., Hoppins, S. C., & Fink, P. J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800705 · Cited by 18
Expression Status and Prognostic Significance of Gamma-Glutamyl Transpeptidase Family Genes in Hepatocellular Carcinoma
Tian, S., Li, J. J., Guo, Y., Dong, W., & Zheng, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.731144 · Cited by 17
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy
Olguín-Contreras, L. F., Mendler, A. N., Popowicz, G. M., Hu, B., & Noeßner, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750478 · Cited by 16
The Non-N6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
Xu, J., Gao, Z., Liu, K., Yang, F., Zhang, Z., Xue, H., Guo, X. H., Zhang, P., Deng, L., Wang, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809808 · Cited by 17
T cell toxicity induced by tigecycline binding to the mitochondrial ribosome
Shao, Q., Khawaja, A., Nguyen, M. D., Singh, V., Zhang, J., Liu, Y., Nordin, J., Adori, M., Axel Innis, C., Castro Dopico, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59388-9 · Cited by 16
Breaking hypoxic barrier: Oxygen-supplied nanomaterials for enhanced T cell-mediated tumor immunotherapy
Xiang, S., Zhan, H., Zhan, J., Li, X., Lin, X., & Sun, W. (2025) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2025.100400 · Cited by 16
Metabolism of Immune Cells in the Tumor Microenvironment
Jung, J. G., & Le, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-65768-0_13 · Cited by 16
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
Lontos, K., Wang, Y., Colbert, M., Kumar, A., Joshi, S. K., Philbin, M., Wang, Y., Frisch, A. T., Lohmueller, J. J., Rivadeneira, D. B., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2131229 · Cited by 16
Self-citation
Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
Li, F., Wang, Y. J., Chen, D., & Du, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031396 · Cited by 17
Treg Cells Survive and Thrive in Inhospitable Environments
Grzes, K. M., Field, C. S., & Pearce, E. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.012 · Cited by 16
Metabolic orchestration of T lineage differentiation and function
Yong, C. S. M., Moussa, D. A., Cretenet, G., Kinet, S., Dardalhon, V., & Taylor, N. N. (2017) · FEBS Letters · doi:10.1002/1873-3468.12849 · Cited by 16
Persistent lineage plasticity driving lung cancer development and progression
Meng, F., Li, J., Xia, Z., Wang, Q., Sun, Q., Wang, S., Xu, L., & Yin, R. H. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70458 · Cited by 17
Spatial microbiome-metabolic crosstalk drives CD8+ T-cell exhaustion through the butyrate-HDAC axis in colorectal cancer
Chen, X., Zhang, Y., Zhang, G., Wang, D., Dou, L., Wang, Y., Huang, Z., & Liu, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1704491 · Cited by 15
The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
Hunt, E. G., Andrews, A. M., Larsen, S. R., & Thaxton, J. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.867341 · Cited by 16
Elevated nuclear PIGL disrupts the cMyc/BRD4 axis and improves PD-1 blockade therapy by dampening tumor immune evasion
Yu, H. T., Shi, T., Yao, L., Xu, D., Ding, Y., Xia, Q., Liu, W., & Wang, X. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01048-3 · Cited by 15
Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens
Chi, H., Su, L., Yan, Y., Gu, X., Su, K., Han, L., Yu, L., Liu, J., Wang, J., Wu, Q., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1375143 · Cited by 15
LKB1 prevents ILC2 exhaustion to enhance antitumor immunity
Niu, H., Zhang, H., Wang, D., Zhao, L., Zhang, Y., Zhou, W., Zhang, J., Su, X., Sun, J., Su, B., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2023.113579 · Cited by 15
From metabolism to malignancy: the multifaceted role of PGC1α in cancer
Wang, Y., Peng, J., Yang, D., Xing, Z., Jiang, B., Xu, D., Jiang, C., Ouyang, B., & Su, L. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1383809 · Cited by 19
How modulation of the tumor microenvironment drives cancer immune escape dynamics
Shrestha, P., Ghoreyshi, Z. S., & George, J. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-91396-z · Cited by 15
Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy
Mollace, A., Coluccio, M. L., Donato, G., Mollace, V., & Malara, N. (2021) · Oncotarget · doi:10.18632/oncotarget.27990 · Cited by 15
Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
Lin, Y., Ruze, R., Zhang, R., Tuergan, T., Wang, M., Tulahong, A., Zhu, D., Yuan, Z., Jiang, T., Aji, T., et al. (2024) · Liver Cancer · doi:10.1159/000542578 · Cited by 17
Mechanisms of T-cell Depletion in Tumors and Advances in Clinical Research
Su, X., Zhang, M., Zhu, H., Cai, J., Wang, Z., Xu, Y., Wang, L., Shen, C., & Cai, M. M. (2025) · Biological Procedures Online · doi:10.1186/s12575-025-00265-6 · Cited by 14
Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression
Li, G., Li, D., & Zhu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1662145 · Cited by 17
Mitochondrial transfer at the crossroads of cancer, stromal, and immune cells
Ishino, T., Inutsuka, Y., Ikeda, H., & Togashi, Y. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.10.004 · Cited by 17
Hierarchical transcriptional network governing heterogeneous T cell exhaustion and its implications for immune checkpoint blockade
Tian, W., Qin, G., Jia, M., Li, W., Cai, W., Wang, H., Zhao, Y., Bao, X., Wei, W., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198551 · Cited by 16
Cell Identity and Spatial Distribution of PD‐1/PD‐L1 Blockade Responders
Li, X., Liu, Y., Gui, J., Gan, L., & Xue, J. (2024) · Advanced Science · doi:10.1002/advs.202400702 · Cited by 17
Impact of mitochondrial dysfunction on the antitumor effects of immune cells
Wang, Q., Yin, X., Huang, X., Zhang, L., & Lu, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1428596 · Cited by 17
Powering immunity: mitochondrial dynamics in natural killer cells
Verhezen, T., Wouters, A., Smits, E., & Waele, J. D. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.04.004 · Cited by 13
Label-free metabolic imaging monitors the fitness of chimeric antigen receptor T cells
Pham, D. L., Cappabianca, D., Forsberg, M. H., Weaver, C., Mueller, K. P., Tommasi, A. M., Vidugirienė, J., Lauer, A. C., Sylvester, K., Lika, J., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01504-7 · Cited by 13
Targeting immuno-metabolism to improve anti-cancer therapies
Beezhold, K., & Byersdorfer, C. A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.005 · Cited by 14
Staphylococcal Enterotoxin C2 Mutant–Directed Fatty Acid and Mitochondrial Energy Metabolic Programs Regulate CD8+ T Cell Activation
Fu, X., Xu, M., Zhang, H., Li, Y., Li, Y., & Zhang, C. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000538 · Cited by 14
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma
Ruff, A., Ballard, H. J., Pantel, A. R., Namoglu, E. C., Hughes, M. E., Nasta, S. D., Chong, E. A., Bagg, A., Ruella, M., Farwell, M. D., et al. (2021) · Molecular Imaging and Biology · doi:10.1007/s11307-021-01627-8 · Cited by 14
A platform for high-throughput bioenergy production phenotype characterization in single cells
Kelbauskas, L., Glenn, H. L., Anderson, C., Messner, J., Lee, K. B., Song, G., Houkal, J., Su, F., Zhang, L., Tian, Y., et al. (2017) · Scientific Reports · doi:10.1038/srep45399 · Cited by 14
Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer
Aria, H., Ghaedrahmati, F., & Ganjalıkhani-Hakemi, M. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30303 · Cited by 14
Metabolic Dialogue Shapes Immune Response in the Tumor Microenvironment
Gao, F., Shah, R., Xin, G., & Wang, R. (2025) · European Journal of Immunology · doi:10.1002/eji.202451102 · Cited by 15
USP25 deficiency promotes T cell dysfunction and transplant acceptance via mitochondrial dynamics
Li, J., Wang, J., Pan, T., Zhou, X., Yang, H., Wang, L., Huang, G., Dai, C., Yang, B., Zhang, B., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109917 · Cited by 13
Hurdle or thruster: Glucose metabolism of T cells in anti-tumour immunity
Zhang, S., Zhang, X., Yang, H., Liang, T., & Bai, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189022 · Cited by 14
Overexpression of AMPKγ2 increases AMPK signaling to augment human T cell metabolism and function
Braverman, E. L., McQuaid, M. A., Schuler, H., Qin, M., Hani, S., Hippen, K. L., Monlish, D. A., Dobbs, A. K., Ramsey, M. J., Kemp, F., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105488 · Cited by 11
Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy
Liu, Y., Wang, T., Ma, W., Jia, Z., Wang, Q., Zhang, M., Luo, Y., & Sun, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1327717 · Cited by 15
Harnessing the capacity of phytochemicals to enhance immune checkpoint inhibitor therapy of cancers: A focus on brain malignancies
Afshari, A. R., Sanati, M., Ahmadi, S. S., Kesharwani, P., & Sahebkar, A. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216955 · Cited by 14
Covalent Plant Natural Product that Potentiates Antitumor Immunity
Takemoto, M., Delghandi, S., Abo, M., Yurimoto, K., Odagi, M., Singh, V. P., Wang, J., Nakagawa, R., Sato, S., Takemoto, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c17837 · Cited by 14
The interactions between major immune effector cells and Hepatocellular Carcinoma: A systematic review
Schoenberg, M. B., Li, X., Li, X., Han, Y., Börner, N., Koch, D. T., Guba, M. O., Werner, J. M., & Bazhin, A. V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108220 · Cited by 12
Principles of reproducible metabolite profiling of enriched lymphocytes in tumors and ascites from human ovarian cancer
Kilgour, M. K., MacPherson, S., Zacharias, L. G., LeBlanc, J., Babinszky, S., Kowalchuk, G., Parks, S. K., Sheldon, R. D., Jones, R. G., DeBerardinis, R. J., et al. (2022) · Nature Protocols · doi:10.1038/s41596-022-00729-z · Cited by 13
Understanding lymphocyte metabolism for use in cancer immunotherapy
MacPherson, S., Kilgour, M. K., & Lum, J. J. (2018) · FEBS Journal · doi:10.1111/febs.14454 · Cited by 14
Plasticity in T-cell mitochondrial metabolism: A necessary peacekeeper during the troubled times of persistent HIV-1 infection
Loucif, H., Dagenais-Lussier, X., Beji, C., Telittchenko, R., Routy, J., & van Grevenynghe, J. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.02.004 · Cited by 12
Reprogramming CD8+ T-cell Branched N- Glycosylation Limits Exhaustion, Enhancing Cytotoxicity and Tumor Killing
Azevedo, C. M., Xie, B., Gunn, W. G., Peralta, R. M., Dantas, C. S., Fernandes-Mendes, H., Joshi, S. K., Dean, V. G., Almeida, P., Wilfahrt, D. N., et al. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-25-0313 · Cited by 13
Self-citation
Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure
Yin, P., Yang, J.-G., Jiang, Y., Han, L., Xiong, T.-C., Liu, H., Fang, Y., Ruan, W., Wu, J., Chen, L., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw3571 · Cited by 13
The coenzyme A precursor pantethine enhances antitumor immunity in sarcoma
MIALLOT, R., Millet, V., Roger, A., Fenouil, R., Tardivel, C., Martin, J., Tranchida, F., Shintu, L., BERCHARD, P., Lanza, J. S., et al. (2023) · Life Science Alliance · doi:10.26508/lsa.202302200 · Cited by 14
Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer
Ma, J., Song, J., Yi, X., Zhang, S., Sun, L., Huang, L., & Han, C. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03582-5 · Cited by 13
Reprogramming T-cell metabolism to enhance adoptive cell therapies
Kates, M., & Saibil, S. D. (2024) · International Immunology · doi:10.1093/intimm/dxae007 · Cited by 13
Tuning cellular metabolism for cancer virotherapy
Xiong, D., Wang, Q., Wang, W., & Sun, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216924 · Cited by 12
Predictors of response and resistance to checkpoint inhibitors in solid tumors
Rao, S., Moran, A. E., & Graff, J. N. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.09.35 · Cited by 14
The Road Less Taken: Less Appreciated Pathways for Manipulating CD8+ T Cell Exhaustion
Pichler, A., Cannons, J. L., & Schwartzberg, P. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.926714 · Cited by 13
Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
Zhou, Y., Zhang, A., Fang, C., Yuan, L., Shao, A., Xu, Y., & Zhou, D. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14315 · Cited by 12
Physiological activation of Aryl hydrocarbon receptor by food-derived ligands is essential for the efficacy of anti-PD1 therapy
de Juan, A., Coillard, A., Cros, A., Rigamonti, A., Alaoui, L., Sampaio, J. L., Monot, N., Balvay, A., Foussier, A., Rieux-Laucat, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66854-x · Cited by 15
Hypoxic microenvironment in cancer: role in metabolic reprogramming
Sureka, N., Maheshwari, R., Agravat, A., Singhal, S., Zaman, S., Rishi, B., Siraj, F., Zaheer, S., & Misra, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771365 · Cited by 11
Sindbis Virus Vaccine Platform: A Promising Oncolytic Virus-Mediated Approach for Ovarian Cancer Treatment
Pampeno, C., Opp, S., Hurtado, A. M., & Meruelo, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052925 · Cited by 11

Authors: Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M.
Affiliations: University of Pittsburgh (US)
UPMC Hillman Cancer Center (US)
Corresponding author: Delgoffe, Greg M.
ORCID: Scharping, Nicole E.
Menk, Ashley V.
Dadey, Rebekah E.
Watkins, Simon C.
Ferris, Robert L.
Delgoffe, Greg M.
Venue: Immunity
Publisher: Elsevier BV
Published: 2016-08
Volume: 45
Issue: 2
Pages: 374-388
ISSN: 1074-7613 (ISSN-L)
DOI: 10.1016/j.immuni.2016.07.009
PMC: PMC5207350
OpenAlex: W4294138012
Cited by: 848
References: 44
Citations by year: 2026: 136 · 2025: 111 · 2024: 113 · 2023: 97 · 2022: 109 · 2021: 90 · 2020: 76 · 2019: 42 · 2018: 33 · 2017: 34 · 2016: 7
FWCI: 20.82
Type: journal article
Language: en
Update notices: erratum (2016-09-20)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 380 d)
Locations: Immunity (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (1s10od016236-01)
National Cancer Institute (P50CA121973, P50CA097190, P30CA047904)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: tumor microenvironment, PGC-1α, Akt signaling, T cell metabolism, oxidative metabolism, tumor-infiltrating T cells, T cell dysfunction, immunosuppression, metabolic reprogramming, cancer immunotherapy
MeSH terms: Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Neoplasms, Experimental, T-Lymphocytes, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Oxidative Stress, Cell Line, Tumor, PPAR gamma, Oncogene Protein v-akt, Mice, Tumor Microenvironment, Cellular Reprogramming

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks